Svetlana H.
- Country
- Slovakia
- Department
- 2706:Ambulancia klinickej imunológie a alergológie
Research Overview
- Long-term Efficacy, Safety, and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria: An Extension Study for Phase 3 Completers
- A multicenter, randomized, double-blind, placebo-controlled, Phase II platform study to assess the efficacy and safety of investigational compound(s) in patients with moderate to severe atopic dermatitis
Data & Insights
Has run more than one trial at 15 of 90 partner sites.
Specializations
Dermatological Research
The investigator specializes in studying chronic spontaneous urticaria, focusing on innovative therapeutic approaches for managing this chronic skin condition.
- Long-term urticaria management
- Treatment efficacy assessment
- Chronic skin conditions
Their work encompasses evaluation of novel therapeutic agents and their sustained effectiveness in dermatological conditions.
Clinical Immunology
The investigator's expertise extends to immunological aspects of skin disorders, with particular attention to therapeutic interventions in immune-mediated conditions.
- Immunological response monitoring
- Therapeutic tolerance assessment
- Long-term safety evaluation
Their research involves investigating immune system responses in chronic skin conditions and their therapeutic management.
Therapeutic Innovation
The investigator focuses on evaluating novel treatment approaches for chronic urticaria, including long-term effectiveness and patient outcomes.
- Treatment optimization strategies
- Extended therapy assessment
- Patient response monitoring
Their work includes assessment of therapeutic interventions and their impact on patient well-being over extended periods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.